Biotech

All Articles

8 months after a $213M fundraise, gene publisher Volume creates reduces

.After raising $213 million in 2023-- among the year's biggest personal biotech rounds-- Tome Biosci...

BioMarin builds director team along with biotech veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings and...

Biopharma Q2 VC attacked highest degree given that '22, while M&ampA slowed

.Venture capital financing right into biopharma cheered $9.2 billion across 215 deals in the second ...

Bicara, Zenas seek IPOs to drive late-phase resources toward market

.Bicara Therapies and also Zenas Biopharma have actually offered new catalyst to the IPO market alon...

Genentech to shut cancer cells immunology research department

.Genentech is going to close its own cancer cells immunology analysis division, and also unit head a...

Kezar drops strong cyst but to show its own really worth in period 1 trial

.Kezar Life Sciences is dropping its own dim stage 1 sound growth medication as the biotech goes all...

Acelyrin loses izokibep, lays off 3rd of staff

.Despite izokibep preserving its newly found winning streak in the medical clinic, Acelyrin is no lo...

Rivus' stage 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medication ca...

Ovid stops preclinical job, IV system after soticlestat fail

.Ovid Therapeutics actually disclosed final month that it was trimming its headcount as the company ...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has opened a $700 thousand R&ampD facility in the Boston ma Seaport, improving its own RN...